Relevant Ongoing Clinical Trials to Investigate Local‐Regional Treatment Strategies for Peritoneal Surface Malignancies

ABSTRACT Background and Objectives The multimodal therapy of peritoneal metastases of common cancers (i.e. colorectal, gastric, and ovarian), including CRS plus HIPEC, is still subject to several clinical studies. Methods This paper presents the ongoing studies regarding HIPEC, as found on clinicalt...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Journal of surgical oncology Ročník 130; číslo 6; s. 1349 - 1357
Hlavní autori: Blaj, S., Häusler, S., Piso, P.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Wiley Subscription Services, Inc 01.11.2024
Predmet:
Chemotherapy, Cancer, Regional Perfusion
Clinical Trials as Topic
Clinical Trials, Phase III as Topic
Combined Modality Therapy
Cytoreduction Surgical Procedures
cytoreductive surgery
Humans
Hyperthermia, Induced
Hyperthermic Intraperitoneal Chemotherapy
ongoing studies
Peritoneal Neoplasms - secondary
Peritoneal Neoplasms - therapy
Stomach Neoplasms - pathology
ongoing studies
hyperthermic intraperitoneal chemotherapy
cytoreductive surgery
ISSN:0022-4790, 1096-9098, 1096-9098
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract ABSTRACT Background and Objectives The multimodal therapy of peritoneal metastases of common cancers (i.e. colorectal, gastric, and ovarian), including CRS plus HIPEC, is still subject to several clinical studies. Methods This paper presents the ongoing studies regarding HIPEC, as found on clinicaltrials.gov. The emphasis was set on Phase III recruiting trials, including the newest information from principal investigators who answered the call of the authors. Results Ninety trials have been identified, and the protocols of 15 studies have been presented in detail. Conclusions There are interesting ongoing trials investigating the role of CRS plus HIPEC.
AbstractList Background and ObjectivesThe multimodal therapy of peritoneal metastases of common cancers (i.e. colorectal, gastric, and ovarian), including CRS plus HIPEC, is still subject to several clinical studies.MethodsThis paper presents the ongoing studies regarding HIPEC, as found on clinicaltrials.gov. The emphasis was set on Phase III recruiting trials, including the newest information from principal investigators who answered the call of the authors.ResultsNinety trials have been identified, and the protocols of 15 studies have been presented in detail.ConclusionsThere are interesting ongoing trials investigating the role of CRS plus HIPEC.
The multimodal therapy of peritoneal metastases of common cancers (i.e. colorectal, gastric, and ovarian), including CRS plus HIPEC, is still subject to several clinical studies. This paper presents the ongoing studies regarding HIPEC, as found on clinicaltrials.gov. The emphasis was set on Phase III recruiting trials, including the newest information from principal investigators who answered the call of the authors. Ninety trials have been identified, and the protocols of 15 studies have been presented in detail. There are interesting ongoing trials investigating the role of CRS plus HIPEC.
ABSTRACT Background and Objectives The multimodal therapy of peritoneal metastases of common cancers (i.e. colorectal, gastric, and ovarian), including CRS plus HIPEC, is still subject to several clinical studies. Methods This paper presents the ongoing studies regarding HIPEC, as found on clinicaltrials.gov. The emphasis was set on Phase III recruiting trials, including the newest information from principal investigators who answered the call of the authors. Results Ninety trials have been identified, and the protocols of 15 studies have been presented in detail. Conclusions There are interesting ongoing trials investigating the role of CRS plus HIPEC.
The multimodal therapy of peritoneal metastases of common cancers (i.e. colorectal, gastric, and ovarian), including CRS plus HIPEC, is still subject to several clinical studies.BACKGROUND AND OBJECTIVESThe multimodal therapy of peritoneal metastases of common cancers (i.e. colorectal, gastric, and ovarian), including CRS plus HIPEC, is still subject to several clinical studies.This paper presents the ongoing studies regarding HIPEC, as found on clinicaltrials.gov. The emphasis was set on Phase III recruiting trials, including the newest information from principal investigators who answered the call of the authors.METHODSThis paper presents the ongoing studies regarding HIPEC, as found on clinicaltrials.gov. The emphasis was set on Phase III recruiting trials, including the newest information from principal investigators who answered the call of the authors.Ninety trials have been identified, and the protocols of 15 studies have been presented in detail.RESULTSNinety trials have been identified, and the protocols of 15 studies have been presented in detail.There are interesting ongoing trials investigating the role of CRS plus HIPEC.CONCLUSIONSThere are interesting ongoing trials investigating the role of CRS plus HIPEC.
Author Häusler, S.
Blaj, S.
Piso, P.
Author_xml – sequence: 1
  givenname: S.
  orcidid: 0000-0001-5830-9797
  surname: Blaj
  fullname: Blaj, S.
  email: sebastian.blaj@barmherzige-regensburg.de
  organization: Hospital Barmherzige Brüder
– sequence: 2
  givenname: S.
  surname: Häusler
  fullname: Häusler, S.
  organization: Hospital Fürth
– sequence: 3
  givenname: P.
  orcidid: 0000-0001-7146-4505
  surname: Piso
  fullname: Piso, P.
  organization: Hospital Barmherzige Brüder
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39491890$$D View this record in MEDLINE/PubMed
BookMark eNp10ctOGzEUBmCrooJwWfQFKkvdtIsBX8ae8bKKoASlCiKwHjnO8cjRxKb2DFV2PEKfsU-Ck0AXlVh5cT7_8u9zjA588IDQJ0rOKSHsYpXCOatqwT-gESVKFoqo-gCN8owVZaXIETpOaUUIUUqWh-iIq1LRWpER2txBB0_a93jm2-B8i8ed887oDt9Hp7uE-4An_glS71rdA56GPPv7_OcOWhf8joHu15AT5n3MonWQsA0R30J0fX5oNvMhWm0A_9Sda732JptT9NHmfDh7PU_Qw9Xl_fi6mM5-TMbfp4XhlPPC0FKWVix0xcVC6TI3oNxaKgxQaa00IJkGC0xqQrlc1qIipWagjKjBiIqfoK_73McYfg25R7N2yUDXaQ9hSA2njNdEcCYy_fIfXYUh5pJbJSWvOKtZVp9f1bBYw7J5jG6t46Z5-9QMvu2BiSGlCPYfoaTZLqzJC2t2C8v2Ym9_uw4278PmZj7b33gBzWeYYQ
Cites_doi 10.3390/cancers13143430
10.1016/S1470-2045(20)30599-4
10.1001/jamasurg.2021.1642
10.1002/jso.21519
10.1245/s10434-023-13116-z
10.1200/JCO.22.02867
10.1200/JCO.2023.41.16_suppl.5510
10.3389/fmed.2023.1070362
10.1200/JCO.2003.04.187
10.1056/NEJMoa1708618
ContentType Journal Article
Copyright 2024 Wiley Periodicals LLC.
2025 Wiley Periodicals LLC.
Copyright_xml – notice: 2024 Wiley Periodicals LLC.
– notice: 2025 Wiley Periodicals LLC.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1002/jso.27853
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1096-9098
EndPage 1357
ExternalDocumentID 39491890
10_1002_jso_27853
JSO27853
Genre reviewArticle
Journal Article
Review
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AAQQT
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GLUZI
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IH2
IX1
J0M
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6P
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
V8K
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
X7M
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGXDD
AGYGG
AIDQK
AIDYY
CITATION
O8X
AGQPQ
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
ID FETCH-LOGICAL-c3133-c1464f5ba735b9a499613ff15ce16ff6ce62aefe26a0136d85704a2e9c58ec573
IEDL.DBID DRFUL
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001357441600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0022-4790
1096-9098
IngestDate Wed Oct 01 15:07:52 EDT 2025
Sat Nov 29 14:31:55 EST 2025
Mon Jul 21 06:01:34 EDT 2025
Sat Nov 29 05:17:13 EST 2025
Fri Feb 14 09:50:45 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords ongoing studies
hyperthermic intraperitoneal chemotherapy
cytoreductive surgery
Language English
License 2024 Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3133-c1464f5ba735b9a499613ff15ce16ff6ce62aefe26a0136d85704a2e9c58ec573
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0001-5830-9797
0000-0001-7146-4505
PMID 39491890
PQID 3166373282
PQPubID 1016364
PageCount 9
ParticipantIDs proquest_miscellaneous_3123805325
proquest_journals_3166373282
pubmed_primary_39491890
crossref_primary_10_1002_jso_27853
wiley_primary_10_1002_jso_27853_JSO27853
PublicationCentury 2000
PublicationDate November 2024
PublicationDateYYYYMMDD 2024-11-01
PublicationDate_xml – month: 11
  year: 2024
  text: November 2024
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Journal of surgical oncology
PublicationTitleAlternate J Surg Oncol
PublicationYear 2024
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2023; 10
2021; 13
2024; 42
2023; 30
2021; 22
2021; 156
2003; 21
2010; 101
2018; 378
e_1_2_10_9_1
e_1_2_10_10_1
e_1_2_10_11_1
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_3_1
e_1_2_10_6_1
e_1_2_10_5_1
e_1_2_10_8_1
e_1_2_10_7_1
References_xml – volume: 22
  start-page: 256
  issue: 2
  year: 2021
  end-page: 266
  article-title: UNICANCER‐GI Group and BIG Renape Group. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Versus Cytoreductive Surgery Alone for Colorectal Peritoneal Metastases (PRODIGE 7): A Multicentre, Randomised, Open‐Label, Phase 3 Trial
  publication-title: The Lancet Oncology
– volume: 42
  start-page: 146
  issue: 2
  year: 2024
  end-page: 156
  article-title: Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC‐I Trial
  publication-title: Journal of Clinical Oncology
– volume: 156
  start-page: 710
  issue: 8
  year: 2021
  end-page: 720
  article-title: Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial
  publication-title: JAMA surgery
– volume: 101
  start-page: 457
  issue: 6
  year: 2010
  end-page: 464
  article-title: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy to Treat Gastric Cancer With Ascites and/or Peritoneal Carcinomatosis: Results From a Chinese Center
  publication-title: Journal of Surgical Oncology
– volume: 10
  year: 2023
  article-title: First Experience with 224Radium‐labeled Microparticles (Radspherin®) After CRS‐HIPEC for Peritoneal Metastasis in Colorectal Cancer (A Phase 1 Study)
  publication-title: Frontiers in Medicine (Lausanne)
– volume: 13
  issue: 14
  year: 2021
  article-title: Preclinical In Vivo‐Models to Investigate HIPEC; Current Methodologies and Challenges
  publication-title: Cancers
– volume: 21
  start-page: 3737
  issue: 20
  year: 2003
  end-page: 3743
  article-title: Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer
  publication-title: Journal of Clinical Oncology
– volume: 378
  start-page: 230
  issue: 3
  year: 2018
  end-page: 240
  article-title: Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
  publication-title: New England Journal of Medicine
– volume: 30
  start-page: 2678
  issue: 5
  year: 2023
  end-page: 2688
  article-title: Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient‐Reported Outcomes of a Randomized Phase II Trial
  publication-title: Annals of Surgical Oncology
– ident: e_1_2_10_11_1
  doi: 10.3390/cancers13143430
– ident: e_1_2_10_3_1
  doi: 10.1016/S1470-2045(20)30599-4
– ident: e_1_2_10_8_1
  doi: 10.1001/jamasurg.2021.1642
– ident: e_1_2_10_4_1
  doi: 10.1002/jso.21519
– ident: e_1_2_10_9_1
  doi: 10.1245/s10434-023-13116-z
– ident: e_1_2_10_5_1
  doi: 10.1200/JCO.22.02867
– ident: e_1_2_10_7_1
  doi: 10.1200/JCO.2023.41.16_suppl.5510
– ident: e_1_2_10_10_1
  doi: 10.3389/fmed.2023.1070362
– ident: e_1_2_10_2_1
  doi: 10.1200/JCO.2003.04.187
– ident: e_1_2_10_6_1
  doi: 10.1056/NEJMoa1708618
SSID ssj0009964
Score 2.424686
SecondaryResourceType review_article
Snippet ABSTRACT Background and Objectives The multimodal therapy of peritoneal metastases of common cancers (i.e. colorectal, gastric, and ovarian), including CRS...
The multimodal therapy of peritoneal metastases of common cancers (i.e. colorectal, gastric, and ovarian), including CRS plus HIPEC, is still subject to...
Background and ObjectivesThe multimodal therapy of peritoneal metastases of common cancers (i.e. colorectal, gastric, and ovarian), including CRS plus HIPEC,...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 1349
SubjectTerms Chemotherapy, Cancer, Regional Perfusion
Clinical Trials as Topic
Clinical Trials, Phase III as Topic
Combined Modality Therapy
Cytoreduction Surgical Procedures
cytoreductive surgery
Humans
Hyperthermia, Induced
Hyperthermic Intraperitoneal Chemotherapy
ongoing studies
Peritoneal Neoplasms - secondary
Peritoneal Neoplasms - therapy
Stomach Neoplasms - pathology
Title Relevant Ongoing Clinical Trials to Investigate Local‐Regional Treatment Strategies for Peritoneal Surface Malignancies
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjso.27853
https://www.ncbi.nlm.nih.gov/pubmed/39491890
https://www.proquest.com/docview/3166373282
https://www.proquest.com/docview/3123805325
Volume 130
WOSCitedRecordID wos001357441600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1096-9098
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0009964
  issn: 0022-4790
  databaseCode: DRFUL
  dateStart: 19960101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fS-NAEB-0yuGLnt6dxn-s4sO95Gw2m2wWn0Qtx1G1tAp9C8lmtpxIK00r-OZH8DP6SZzNn5ZyHBzcWyATNuzM7Pxmd-c3ACcizcIQdeZm0qArPJm6ERrKUoTNxQJNQaNsNiFvbqJ-X3WW4KyuhSn5IWYbbtYzivXaOniS5qdz0tCHfPSDS4o2y7DCyW6DBqxcdlv37TnnrgpFTRYupGrWxEJNfjr7eDEc_YExFyFrEXNaG__1t59hvYKa7Ly0jU1YwuEWfLquDtO_wEvX1pbTzLLb4WBEIYxVJKGP7K4wSzYZsTkPB7K2jXvvr29dHBQbiCRW3VJnNckt5oxQMOuQXVuWb5LpTccm0ciuCfAPyl7A-Ve4b13dXfx0q04MrvYpiXU1rafCBGki_SBVCWVJhAKM8QKNXmhMqDHkCRrkYWI54DLLmi8SjkoHEepA-t-gMaRRd4AZySmZF8bnGAqdcoVoMp1JC_V1M_McOK4VEj-VhBtxSa3MY5rEuJhEB_ZrVcWVz-Wx7xF6stxD3IGj2WvyFnsEkgxxNLUyBFFsM4zAge1SxbNRfCWUF6mmA98LTf59-PhX77Z42P130T1Y44SHyjLGfWhMxlM8gFX9PPmdjw9hWfajw8qAPwCLe_T9
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9tAEB7xEuUCtOVhoLBUPfRiiNdrb1bigqAR0CSgEKTcLHs9G7WqEhQnSNz4CfxGfgmzfiRCVaVK3Cx5rLV2Zna-2d35BuCbSNIwRJ26qTToCk8mbh0NZSnC5mKBpqBRNJuQ7Xa911M3c3BS1cIU_BDTDTfrGfl6bR3cbkgfz1hDf2fDIy4p3MzDoiAzIvtePO807poz0l0ViootXEhVq5iFavx4-vHbePQXyHyLWfOg01h73--uw2oJNtlpYR0fYQ4Hn2C5VR6nf4bHjq0up7ll14P-kIIYK2lC_7BubphsPGQzJg5kTRv5Xp6eO9jPtxBJrLynziqaW8wY4WB2Q5Zteb5J5nYyMrFG1iLI3y-6AWcbcNf40T27cMteDK72KY11Na2owgRJLP0gUTHlSYQDjPECjV5oTKgx5DEa5GFsWeBSy5svYo5KB3XUgfQ3YWFAo24DM5JTOi-MzzEUOuEK0aQ6lRbs61rqOfC10kh0X1BuRAW5Mo9oEqN8Eh3Yq3QVlV6XRb5H-MmyD3EHDqevyV_sIUg8wOHEyhBIse0wAge2Ch1PR_GVUF5d1Rz4nqvy38NHV7fX-cPO_4sewIeLbqsZNS_bP3dhhRM6Kooa92BhPJrgF1jSD-Nf2Wi_tONXZ-X4BQ
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9tAEB5cJ4Rc-kjTVG3abkIOuai2ViutF3opdU0efmEnkJuQVrOmpdjGsgu99Sf0N-aXZFYPGxMKhd4EGrFiZ2bnm92dbwDORJKGIerUTaVBV3gycVtoKEsRNhcLNAWNotmE7Pdbd3dqWINPVS1MwQ-x3nCznpGv19bBcZ6axoY19Hs2-8glhZsnsCNsE5k67LRHndvuhnRXhaJiCxdSNStmoSZvrD_ejkePQOY2Zs2DTufZ__3uc3hagk32ubCOF1DD6QHs9crj9Jfwa2Sry2lu2WA6mVEQYyVN6A92kxsmW87YhokDWddGvvvff0Y4ybcQSay8p84qmlvMGOFgNiTLtjzfJDNeLUyskfUI8k-KbsDZIdx2vt58uXDLXgyu9imNdTWtqMIESSz9IFEx5UmEA4zxAo1eaEyoMeQxGuRhbFngUsubL2KOSgct1IH0X0F9SqO-BmYkp3ReGJ9jKHTCFaJJdSot2NfN1HPgtNJINC8oN6KCXJlHNIlRPokOHFe6ikqvyyLfI_xk2Ye4Ayfr1-Qv9hAknuJsZWUIpNh2GIEDR4WO16P4SiivpZoOnOeq_Pvw0dV4kD-8-XfRD7A3bHei7mX_-i3scwJHRU3jMdSXixW-g139c_ktW7wvzfgBAFT3gA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Relevant+Ongoing+Clinical+Trials+to+Investigate+Local-Regional+Treatment+Strategies+for+Peritoneal+Surface+Malignancies&rft.jtitle=Journal+of+surgical+oncology&rft.au=Blaj%2C+S&rft.au=H%C3%A4usler%2C+S&rft.au=Piso%2C+P&rft.date=2024-11-01&rft.issn=1096-9098&rft.eissn=1096-9098&rft_id=info:doi/10.1002%2Fjso.27853&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-4790&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-4790&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-4790&client=summon